当前位置:首页 - 行情中心 - 联影医疗(688271) - 财务分析

联影医疗

(688271)

  

流通市值:1134.78亿  总市值:1134.78亿
流通股本:8.24亿   总股本:8.24亿

联影医疗(688271)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润11.02亿元,每股收益1.36元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益2080534.34万元,未分配利润613165.04万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2975706.06万元,负债895171.72万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入8,858,916,392.736,015,901,402.162,477,948,927.4910,300,104,386.97
营业总成本7,918,571,581.465,075,101,040.912,132,796,705.769,385,271,546.62
其他经营收益
营业利润1,181,126,237.021,076,930,298.74398,763,564.241,366,355,909.25
利润总额1,178,552,726.271,072,972,130.74397,818,460.11,351,707,513.98
净利润1,102,306,203.42987,895,732.3365,525,205.261,241,924,000.46
每股收益
其他综合收益-15,265,169.31-3,315,448.42-2,289,461.426,068,286.44
综合收益总额1,087,041,034.11984,580,283.88363,235,743.841,247,992,286.9
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计21,210,431,619.420,799,367,994.1421,178,583,764.6220,893,841,318.46
非流动资产:
非流动资产合计8,546,628,959.497,879,691,295.317,667,434,752.677,141,847,554.02
资产总计29,757,060,578.8928,679,059,289.4528,846,018,517.2928,035,688,872.48
流动负债:
流动负债合计7,371,869,330.956,774,638,880.767,517,678,845.857,075,747,152.06
非流动负债:
非流动负债合计1,579,847,853.51,117,628,6301,045,532,114.541,053,700,647.75
负债合计8,951,717,184.457,892,267,510.768,563,210,960.398,129,447,799.81
所有者权益(或股东权益):
归属于母公司股东权益合计20,808,504,583.0920,793,840,448.6320,284,291,823.4319,903,165,417.53
股东权益合计20,805,343,394.4420,786,791,778.6920,282,807,556.919,906,241,072.67
负债和股东权益合计29,757,060,578.8928,679,059,289.4528,846,018,517.2928,035,688,872.48
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计10,200,586,354.356,662,412,148.832,959,443,152.0411,289,825,745.87
经营活动现金流出小计10,093,373,089.896,613,652,349.063,312,917,371.6911,908,849,999.12
经营活动产生的现金流量净额107,213,264.4548,759,799.77-353,474,219.65-619,024,253.25
投资活动产生的现金流量:
投资活动现金流入小计25,682,353,343.820,235,713,709.199,963,124,883.4426,962,631,058.47
投资活动现金流出小计27,253,288,329.6419,752,613,018.059,921,075,392.6828,206,938,771.17
投资活动产生的现金流量净额-1,570,934,985.83483,100,691.1442,049,490.76-1,244,307,712.7
筹资活动产生的现金流量:
筹资活动现金流入小计650,608,755.271,749,911.331,855,000648,512,658.86
筹资活动现金流出小计661,626,671.15593,503,208.3510,957,182.39449,539,835.55
筹资活动产生的现金流量净额-11,017,915.95-521,753,297.02-9,102,182.39198,972,823.31
汇率变动对现金及现金等价物的影响-12,481,323.94-717,683.65-571,641.911,581,829.58
现金及现金等价物净增加额-1,487,220,961.279,389,510.24-321,098,553.19-1,662,777,313.06
期末现金及现金等价物余额4,380,634,132.845,877,244,604.355,546,756,540.925,867,855,094.11
补充资料:
现金及现金等价物的净增加额-9,389,510.24--1,662,777,313.06
最新报告期:2025-10-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中金公司俞波,张琎,冯喜鹏2.372.95--2025-10-30
群益证券王睿哲2.282.783.282025-10-30
华泰证券代雯,高鹏,杨昌源2.432.943.542025-10-30
中信建投朱琪璋,王在存,贺菊颖2.372.843.492025-10-13
西部证券陆伏崴2.302.823.452025-09-23
TOP↑